Neurological damage related to cardiac surgery: Pathophysiology, diagnostic tools and prevention strategies. Using actual knowledge for planning the future

Neurologist

Volumn 16, Issue 3, 2010, Pages 152-164

  Carrascal, Yolanda ^a   Guerrero, Angel L ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b NONE

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Cognitive decline; Neuroprotection; Surrogate marker

Indexed keywords

ADENYLATE KINASE; ALLOPURINOL; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ALPHA TOCOPHEROL; APROTININ; ASCORBIC ACID; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CREATINE KINASE BB; DEFEROXAMINE; DEXTROMETHORPHAN; DIAZOXIDE; GANGLIOSIDE GM1; KAINIC ACID RECEPTOR ANTAGONIST; LEXIPAFANT; LIDOCAINE; MANNITOL; MINOCYCLINE; N ACETYLASPARTIC ACID; NAFAMSTAT MESILATE; NEURON SPECIFIC ENOLASE; NIMODIPINE; NITRIC OXIDE SYNTHASE INHIBITOR; PROPOFOL; PROSTACYCLIN; PROTEIN S100B; REMACEMIDE; SUPEROXIDE DISMUTASE; UNINDEXED DRUG;

BIOCHEMISTRY; BRAIN DAMAGE; BRAIN ISCHEMIA; CARDIOPULMONARY BYPASS; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DIFFUSION WEIGHTED IMAGING; DRUG MECHANISM; DRUG MEGADOSE; ELECTROENCEPHALOGRAPHY; HEART SURGERY; HUMAN; NEAR INFRARED SPECTROSCOPY; NERVOUS SYSTEM INJURY; NEUROCHEMISTRY; NEUROLOGICAL COMPLICATION; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURGICAL TECHNIQUE;

BRAIN; BRAIN DAMAGE, CHRONIC; BRAIN ISCHEMIA; CARDIAC SURGICAL PROCEDURES; HUMANS; INTRACRANIAL THROMBOSIS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; STROKE; TIME;

EID: 77952028096     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/NRL.0b013e3181bd602b     Document Type: Review

References (213)

1. Janssen DP, Noyez L, van Druten JA, et al. Predictors of neurological morbidity after coronary artery bypass surgery. Eur J Cardiothorac Surg. 1999; 15: 166-192. (Pubitemid 29156783)
2. Taggart D. Off-pump surgery and cerebral injury. J Thorac Cardiovasc Surg. 2004; 127: 7-9. (Pubitemid 38160458)
3. Jacobs A, Neveling M, Horst M, et al. Alterations of neuropsychological function and cerebral glucose metabolism after cardiac surgery are not related only to intraoperative microembolic events. Stroke. 1998; 29: 660-667. (Pubitemid 28145795)
4. Bucerius J, Gummert JF, Borger MA, et al. Stroke after cardiac surgery: a risk factor analysis of 16, 184 consecutive adult patients. Ann Thorac Surg. 2003; 75: 472-478. (Pubitemid 36184491)
5. Hogue CW, Sundt TM, Goldberg M, et al. Neurological complications of cardiac surgery: the need for new paradigms in prevention and treatment. Semin Thorac Cardiovasc Surg. 1999; 11: 105-115.
6. Baumgartner WA. Neuroprotection in cardiac surgery. Ann Thorac Surg. 2005; 79: S2254-S2256.
7. Stolz E, Gerriets T, Kluge A, et al. Diffusion-weighted magnetic resonance imaging and neurobiochemical markers after aortic valve replacement. Implications for future neuroprotective trials? Stroke. 2004; 35: 888-892. (Pubitemid 38419797)
8. Frumento RJ, O'Malley CM, Bennet-Guerrero E. Stroke after cardiac surgery: a retrospective analysis of the effect of aprotinin dosing regimens. Ann Thorac Surg. 2003; 75: 479-484.
9. Knipp SC, Matatko N, Wilhelm H, et al. Evaluation of brain injury after coronary artery bypass grafting. A prospective study using neuropsychological assessment and diffusion-weighted magnetic resonance imaging. Eur J Cardiothorac Surg. 2004; 25: 791-800. (Pubitemid 38481994)
10. Wolman RL, Nussmeier N, Aggarwal A, et al. Cerebral injury after cardiac surgery. Identification of a group at extraordinary risk. Stroke. 1999; 30: 514-522. (Pubitemid 29115385)
11. Shaaban Ali M, Harmer M, Vaughan R. Serum S100 protein as a marker of cerebral damaging during cardiac surgery. Br J Anaesth. 2000; 85: 287-298. (Pubitemid 30603976)
12. Hogue CW, Murphy SF, Schechtman KB, et al. Risk factors or early or delayed stroke after cardiac surgery. Circulation. 1999; 100: 642-647.
13. Svedjeholm R, Hakanson E, Szabo Z, et al. Neurological injury after surgery for ischemic heart disease: risk factors, outcome and role of metabolic interventions. Eur J Cardiothorac Surg. 2001; 19: 611-618. (Pubitemid 32416613)
14. Taggart DP, Westaby S. Neurological and cognitive disorders after coronary artery bypass grafting. Curr Opin Cardiol. 2001; 16: 271-276. (Pubitemid 32953602)
15. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med. 1996; 335: 1857-1863. (Pubitemid 26419192)
16. Hypothermia, circulatory arrest and cardiopulmonary bypass. In: Kirklin JW, Barrat-Boyes BG, eds. Cardiac Surgery. 2nd ed. New York, NY: Churchill Livingstone Inc; 1993: 61-127.
17. Salmenperä MT, Levy JH, Harker L. Hemostasis and cardiopulmonary bypass. In: Mora CT, ed. Cardiopulmonary Bypass. Principles and Techniques of Extracorporeal Circulation. New York, NY: Springer-Verlag; 1995:88-107.
18. Vedin J, Nyman H, Ericsson A, et al. Cognitive function after on or off pump coronary artery bypass grafting. Eur J Cardiothorac Surg. 2006; 30: 305-310. (Pubitemid 44051889)
19. Zamvar V, Williams D, Hall J, et al. Assessment of neurocognitive impairment after off-pump and on-pump techniques for coronary artery bypass graft surgery: prospective randomized controlled trial. BMJ. 2002; 325: 1268-1271. (Pubitemid 35430581)
20. Van Dijk D, Hansen EW, Hijman R, et al. Cognitive outcome after off-pump and on-pump coronary artery bypass surgery: a randomized trial. JAMA. 2002; 287: 1405-1412. (Pubitemid 34250503)
21. Khan NE, Mister R, De Souza AC, et al. A randomized comparison of off-pump and on-pump multivessel coronary-artery bypass surgery. N Engl J Med. 2004; 350: 21-28. (Pubitemid 38032180)
22. Sedrakyan A, Wu AW, Parashar A, et al. Off-pump surgery is associated with reduced occurrence of stroke and other morbidity as compared with traditional coronary artery bypass grafting: a meta-analysis of systematically reviewed trials. Stroke. 2006; 37: 2759-2769. (Pubitemid 44922537)
23. Sharony R, Grossi EA, Saunders PC, et al. Propensity case-matched analysis of off-pump coronary artery bypass grafting in patients with atheromatous aortic disease. J Thorac Cardiovasc Surg. 2004; 127: 406-413. (Pubitemid 38176644)
24. Herrmann M, Ebert AD, Tober D, et al. A contrastive analysis of release patterns of biochemical markers of brain damage after coronary artery bypass grafting and valve replacement and their association with the neurobehavioral outcome after cardiac surgery. Eur J Cardiothorac Surg. 1999; 16: 513-518. (Pubitemid 29528092)
25. Russell D. Cerebral microemboli and cognitive impairment. J Neurol Sci. 2002; 203-204: 211-214. (Pubitemid 35287401)
26. Abu-Omar Y, Balacumaraswami L, Pigott DW, et al. Solid and gaseous cerebral microembolization during off-pump, on-pump, and open cardiac surgery procedures. J Thorac Cardiovasc Surg. 2004; 127: 1759-1765. (Pubitemid 38725458)
27. Guerrieri Wolf L, Abu-Omar Y, Choudhary BP, et al. Gaseous and solid cerebral microembolization during proximal aortic anastomoses in off-pump coronary surgery: the effect of an aortic side-biting clamp and two clampless devices. J Thorac Cardiovasc Surg. 2007; 133: 485-493. (Pubitemid 46136248)
28. Kneebone AC, Luszcz MA, Baker RA, et al. A syndromal analysis of neuropsychological outcome following coronary artery bypass graft surgery. J Neurol Neurosurg Psychiatry. 2005; 76: 1121-1127. (Pubitemid 41081288)
29. Borger MA, Feindel CM. Cerebral emboli during cardiopulmonary bypass: effect of perfusionist interventions and aortic cannulas. J Extra Corpor Technol. 2002; 34: 29-33.
30. Bendszus M, Reents W, Franke D, et al. Brain damage after coronary artery bypass grafting. Arch Neurol. 2002; 59: 1090-1095. (Pubitemid 34755821)
31. Whitaker DC, Stygall J, Newman SP. Neuroprotection during cardiac surgery: strategies to reduce cognitive decline. Perfusion. 2002; 17 (suppl 1) : 69-75. (Pubitemid 34467141)
32. Brooker RF, Brown WR, Moody DM, et al. Cardiotomy suction: a major source of brain lipid emboli during cardiopulmonary bypass. Ann Thorac Surg. 1998; 65: 1651-1655. (Pubitemid 28313624)
33. Brown WR, Moody DM, Challa VR, et al. Longer duration of cardiopulmonary bypass is associated with greater numbers of cerebral microemboli. Stroke. 2000; 31: 707-713.
34. Carrascal Y, Casquero E, Gualis J, et al. Cognitive decline alter cardiac surgery: proposal for easy measurement with a new test. Interact Cardiovasc Thorac Surg. 2005; 4: 216-221. (Pubitemid 41289182)
35. Zinder PJ, Capelleri JC. Information processing speed deficits may be better correlated with the extent of white matter sclerotic lesions in multiple sclerosis than previously suspected. Brain Cogn. 2001; 46: 279-284.
36. Watters MP, Cohen AM, Monk CR, et al. Reduced cerebral embolic signals in beating heart coronary surgery detected by transcranial Doppler ultrasound. Br J Anaesth. 2000; 84: 629-631.
37. Clark RE, Brillman J, Davies DA, et al. Micro emboli during coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1995; 109: 249-258.
38. Bonato R, Pittarello D, Armellin G, et al. The value of transesophageal echocardiography during cardiac surgery. Minerva Anestesiol. 2000; 66: 661.
39. Dalmas JP, Eker A, Girard C, et al. Intracardiac air clearing in valvular surgery guided by transesophageal echocardiography. J Heart Valve Dis. 1996; 5: 553-557. (Pubitemid 26327071)
40. Orihashi K, Matsuura Y, Hamanaka Y, et al. Retained intracardiac air in open heart operations examined by transesophageal echocardiography. Ann Thorac Surg. 1993; 55: 1467-1471. (Pubitemid 23189396)
41. Hartman GS, Yao FS, Bruefach M III, et al. Severity of aortic atheromatous disease diagnosed by transesophageal echocardiography predicts stroke and other outcomes associated with coronary artery surgery: a prospective study. Anesth Analg. 1996; 83: 701-708. (Pubitemid 26349201)
42. Westaby S, Saatvedt K, White S, et al. Is there a relationship between cognitive dysfunction and systemic inflammatory response after cardiopulmonary bypass? Ann Thorac Surg. 2001; 71: 667-672. (Pubitemid 32173853)
43. Whitaker D, Stygall J, Harrison M, et al. Relationship between white cell count, neuropsychologic outcome, and microemboli in 161 patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2006; 131: 1358-1363. (Pubitemid 43776083)
44. Hammon JW. Extracorporeal circulation: perfusion system. In: Cohn LH, ed. Cardiac Surgery in the Adult. New York, NY: McGraw-Hill; 2008: 350-370.
45. Nussmeier NA. Management of temperature during and after cardiac surgery. Tex Heart Inst J. 2005; 32: 472-476.
46. Nathan HJ, Wells GA, Munson JL, et al. Neuroprotective effect of mild hypothermia in patients undergoing coronary artery surgery with cardiopulmonary bypass. Circulation. 2001; 104 (suppl I) : I85-I91. (Pubitemid 32884783)
47. Carrascal Y, Guerrero-Peral AL, Maroto LC, et al. The etiology of neurological complications after cardiac surgery. Rev Neurol. 1997; 12: 807-810. (Pubitemid 27359455)
48. Engleman RM, Pleet AB, Hicks R, et al. Is there a relationship between systemic perfusion temperature during coronary artery bypass grafting and extent of intraoperative ischemic central nervous system injury? J Thorac Cardiovasc Surg. 2000; 119: 230-232. (Pubitemid 30091795)
49. Gaudino M, Martinelli L, Di Lella G, et al. Superior extension of intraoperative brain damage in case of normothermic systemic perfusion during coronary artery bypass operations. J Thorac Cardiovasc Surg. 1999; 118: 432-437. (Pubitemid 29426643)
50. Ali MS, Harmer M, Vaughan RS, et al. Changes in cerebral oxygenation during cold (28 degrees C) and warm (34 degrees C) cardiopulmonary bypass using different blood gas strategies (alpha-stat and pH-stat) in patients undergoing coronary artery bypass graft surgery. Acta Anaesthesiol Scand. 2004; 48: 837-844. (Pubitemid 38993097)
51. Boodhwani M, Rubens FD, Wozny D, et al. Predictors of early neurocognitive deficits in low-risk patients undergoing on-pump coronary artery bypass surgery. Circulation. 2006 4; 114 (suppl 1) : I461-I466. (Pubitemid 44297192)
52. Nathan HJ, Wells GA, Munson JL, et al. Neuroprotective effect of mild hypothermia in patients undergoing coronary artery surgery with cardiopulmonary bypass: a randomized trial. Circulation. 2001; 104 (12 suppl 1) : I85-I91. (Pubitemid 32884783)
53. Nathan HJ, Wells GA, Munson JL, et al. Neuroprotective effect of mild hypothermia in patients undergoing coronary artery surgery with cardiopulmonary bypass: five-year follow-up of a randomized trial. J Thorac Cardiovasc Surg. 2007; 133: 1206-1211.
54. Shaaban-Ali M, Harmer M, Vaughan RS, et al. Changes in serum S100beta protein and Mini-Mental State Examination after cold (28 degrees C) and warm (34 degrees C) cardiopulmonary bypass using different blood gas strategies (alpha-stat and pH-stat). Acta Anaesthesiol Scand. 2002; 46: 10-16. (Pubitemid 34208231)
55. Harris DN, Oatridge A, Dob D, et al. Cerebral swelling after normothermic cardiopulmonary bypass. Anesthesiology. 1998; 88: 340-345. (Pubitemid 28081193)
56. Faraci FM, Heistad DD. Regulation of large cerebral arteries and cerebral microvascular pressure. Circulation Res. 1990; 66: 8-17.
57. Deiss JM, Bojar RM. Cardiopulmonary bypass. In: Bojar JM, ed. Adult Cardiac Surgery. Cambridge, United Kingdom: Blackwell Scientific Publications; 1992: 6
58. Sadahiro M, Haneda K, Mohri H. Experimental study of cerebral autoregulation during cardiopulmonary bypass with or without pulsatile perfusion. J Thorac Cardiovasc Surg. 1994; 108: 446-454. (Pubitemid 24299669)
59. Kiziltan HT, Baltali M, Bilen A, et al. Comparison of alpha-stat and pH-stat cardiopulmonary bypass in relation to jugular venous oxygen saturation and cerebral glucose-oxygen utilization. Anesth Analg. 2003; 96: 644-650. (Pubitemid 36245545)
60. Girdauskas E, Kinduris S. Risk factors for stroke in cardiac surgery patients. Medicina. 2002; 38: 250-260.
61. Halstead JC, Spielvogel D, Meier DM, et al. Optimal pH strategy for selective cerebral perfusion. Eur J Cardiothorac Surg. 2005; 28: 266-273. (Pubitemid 41020695)
62. Nauphal M, El-Khatib M, Taha S, et al. Effect of alpha-stat vs. pH-stat strategies on cerebral oximetry during moderate hypothermic cardiopulmonary bypass. Eur J Anaesthesiol. 2007; 24: 15-19. (Pubitemid 44923840)
63. Piccioni MA, Leirner AA, Auler JO Jr. Comparison of pH-stat versus Alpha-stat during hypothermic cardiopulmonary bypass in the prevention and control of acidosis in cardiac surgery. Artif Organs. 2004; 28: 347-352.
64. Baraka A, Naufal M, El-Khatib M. Correlation between cerebral and mixed venous oxygen saturation during moderate versus tepid hypothermic hemodiluted cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2006; 20: 819-825. (Pubitemid 44809962)
65. DioDato CP, Likosky DS, DeFoe GR, et al. Cardiopulmonary bypass recommendations in adults: the northern New England experience. J Extra Corpor Technol. 2008; 40: 16-20. (Pubitemid 351508042)
66. du Plessis AJ, Jonas RA, Wypij D, et al. Perioperative effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. Thorac Cardiovasc Surg. 1997; 114: 991-1000. (Pubitemid 28023881)
67. Bellinger DC, Wypij D, du Plessis AJ, et al. Developmental and neurologic effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg. 2001; 121: 374-383. (Pubitemid 32150928)
68. Hickey PR. Neurologic sequelae associated with deep hypothermic circulatory arrest. Ann Thorac Surg. 1998; 65 (suppl 6) : S65-S69.
69. Duebener LF, Hagino I, Sakamoto T, et al. Effects of pH management during deep hypothermic bypass on cerebral microcirculation: alpha-stat versus pH-stat. Circulation. 2002; 106 (12 suppl 1) : I103-I108.
70. Halstead JC, Etz C, Meier DM, et al. Perfusing the cold brain: optimal neuroprotection for aortic surgery. Ann Thorac Surg. 2007; 84: 768-774. (Pubitemid 47285031)
71. Di Eusanio M, Schepens MA, Morshuis WJ, et al. Brain protection using selective antegrade cerebral perfusion: a multicenter study. Ann Thorac Surg. 2003; 76: 1181-1188. (Pubitemid 37204730)
72. Strauch JT, Spielvogel D, Lauten A, et al. Technical advances in total aortic arch replacement. Ann Thorac Surg. 2004; 77: 581-589. (Pubitemid 38186515)
73. Siesjo BK. A new perspective on ischemic brain damage? Prog Brain Res. 1993; 96: 1-9.
74. Zauner A, Daugherty WP, Bullock MP, et al. Brain oxygenation and energy metabolism: part I-biological function and pathophysiology. Neurosurgery. 2002; 51: 289-301. (Pubitemid 36322722)
75. Regan RF, Guo YP. Potentiation of excitotoxic injury by high concentrations of extracellular reduced glutathione. Neuroscience. 1999; 91: 463-470.
76. Mizrahi EM, Patel VM, Crawford ES, et al. Hypothermic-induced electrocerebral silence, prolonged circulatory arrest, and cerebral protection during cardiovascular surgery. Electroencephalogr Clin Neurophysiol. 1989; 72: 81-85.
77. Stancák A, Polácek H, Vrána J, et al. Cortical oscillatory changes during warming and heating in humans. Neuroscience. 2007; 147: 842-852. (Pubitemid 46990657)
78. Van der Worp HB, Kraaier V, Wieneke GH, et al. Quantitative EEG during progressive hypocarbia and hypoxia. Hyperventilation-induced EEG changes reconsidered. Electroencephalogr Clin Neurophysiol. 1991; 79: 335-341.
79. Freye E. Cerebral monitoring in the operating room and the intensive care unit-an introductory for the clinician and a guide for the novice wanting to open a window to the brain. Part II: sensory-evoked potentials (SSEP, AEP, VEP). Clin Monit Comput. 2005; 19: 77-168. (Pubitemid 41403402)
80. Hoffman GM. Neurologic monitoring on cardiopulmonary bypass: what are we obligated to do? Ann Thorac Surg. 2006; 81: 2373-2380.
81. Hall RI. Serum S-100B protein and postoperative neurological dysfunctionready for prime time? Can J Anesth. 2004; 51: 645-648. (Pubitemid 39419634)
82. Markowitz SD, Ichord RN, Wernovsky G, et al. Surrogate markers for neurological outcome in children after deep hypothermic circulatory arrest. Semin Cardiothorac Vasc Anesth. 2007; 11: 59-65. (Pubitemid 46280508)
83. Van der Linden J, Hadjinikolau L, Bergman P, et al. Postoperative stroke in cardiac surgery is related to location and extent of atherosclerotic disease in the ascending aorta. J Am Coll Cardiol. 2001; 38: 131-135. (Pubitemid 32613839)
84. Isgro F, Schmidt C, Pohl P, et al. A predictive parameter in patients with brain related complications after cardiac surgery? Eur J Cardiothorac Surg. 1997; 11: 640-644. (Pubitemid 27180132)
85. Hammon JW, Stump D. Commentary: biochemical markers of brain injury after cardiac surgery. J Thorac Cardiovasc Surg. 2000; 119: 130-131. (Pubitemid 30046323)
86. Westaby S, Johnsson P, Parry A. Serum S100 protein: a potential marker for cerebral events during cardiopulmonary bypass. Ann Thorac Surg. 1996; 61: 88-92. (Pubitemid 26053495)
87. Chaturvedi S, Bruno A, Feasby T, et al. Carotid endarterectomy-an evidence-based review: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology. 2005; 65: 794-801. (Pubitemid 41362117)
88. Jönsson H, Johnsson P, Bäckström M, et al. Controversial significance of early S100B levels after cardiac surgery. BMC Neurol. 2001; 4: 245. (Pubitemid 40177006)
89. Kumar P, Dhital K, Hossein-Nia M, et al. S-100 protein release in a range of cardiothoracic surgical procedures. J Thorac Cardiovasc Surg. 1997; 113: 953-954. (Pubitemid 27216507)
90. Grocott HP, Croughwell ND, Amory DW, et al. Cerebral emboli and serum S100β during cardiac operations. Ann Thorac Surg. 1998; 65: 1645-1650. (Pubitemid 28313623)
91. Westaby S, Saatvedt K, White S, et al. Is there a relationship between serum S-100β protein and neuropsychological dysfunction after cardiopulmonary bypass? J Thorac Cardiovasc Surg. 2000; 119: 132-137. (Pubitemid 30046324)
92. Diegeler A, Hirsch R, Schneider F, et al. Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation. Ann Thorac Surg. 2000; 69: 1162-1166. (Pubitemid 30259379)
93. Kilminster S, Treasure T, McMillan T, et al. Neuropsychological change and S-100 protein release in 130 unselected patients undergoing cardiac surgery. Stroke. 1999; 30: 1869-1874. (Pubitemid 29411829)
94. Lloyd CT, Ascione R, Underwood MJ, et al. Serum S-100 protein release and neuropsychologic outcome during coronary revascularization on the beating heart: a prospective randomized study. J Thorac Cardiovasc Surg. 2000; 119: 148-154. (Pubitemid 30046326)
95. Ishida K, Gohara T, Kawata R, et al. Are serum S100beta proteins and neuron-specific enolase predictors of cerebral damage in cardiovascular surgery? J Cardiothorac Vasc Anesth. 2003; 17: 4-9. (Pubitemid 36286441)
96. Gao F, Harris DN, Sapsed-Byrne S. Time course of neurone-specific enolase and S-100 protein release during and after coronary artery bypass grafting. Br J Anaesth. 1999; 82: 266-267. (Pubitemid 29057627)
97. Urenjak J, Williams SR, Gadian DG, et al. Specific expression of N acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. JNeurochem. 1992; 59: 55-61.
98. Pan JW, Takahashi K. Interdependence of N-acetyl aspartate and highenergy phosphates in healthy human brain. Ann Neurol. 2005; 57: 92-97. (Pubitemid 40053319)
99. Georgiadis B, Berger A, Kowatschev E, et al. Predictive value of S-100β and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery. J Thorac Cardiovasc Surg. 2000; 119: 138-147. (Pubitemid 30046325)
100. Siman R, Roberts VL, McNeil E, et al. Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest. Brain Res. 2008; 1213: 1-11.
101. Floyd TF, Shah PN, Price CC, et al. Clinically silent cerebral ischemic events after cardiac surgery: their incidence, regional vascular occurrence, and procedural dependence. Ann Thorac Surg. 2006; 81: 2160-2166.
102. Wahr JA, Tremper KK, Samra S, et al. Near-infrared spectroscopy: theory and applications. J Cardiothorac Vasc Anesth. 1996; 10: 406-418. (Pubitemid 26130305)
103. Shin'oka T, Nollert G, Shum-Tim D, et al. Utility of near-infrared spectroscopic measurements during deep hypothermic circulatory arrest. Ann Thorac Surg. 2000; 69: 578-583. (Pubitemid 30125596)
104. Toner I, Peden CJ, Hamid SK, et al. MRI and neuropsychological changes after coronary artery bypass surgery. J Neurosurg Anesthesiol. 1994; 6: 163-169.
105. Barbut D, Lo YW, Gold JP, et al. Impact of embolisation during coronary artery bypass grafting on outcome and length of stay. Ann Thorac Surg. 1997; 63: 998-1002. (Pubitemid 27191651)
106. Huang JH, Su ZK, Wang SM. Near-infrared spectroscopy monitoring of brain oxygen in infant cardiac surgery. Asian Cardiovasc Thorac Ann. 2007; 15: 194-199. (Pubitemid 47023513)
107. Redlin M, Koster A, Huebler M, et al. Regional differences in tissue oxygenation during cardiopulmonary bypass for correction of congenital heart disease in neonates and small infants: relevance of near-infrared spectroscopy. J Thorac Cardiovasc Surg. 2008; 136: 962-967.
108. Goto T, Baba T, Honma K, et al. Magnetic resonance imaging findings and postoperative neurologic dysfunction in elderly patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2001; 72: 137-142. (Pubitemid 32643024)
109. Kohn A. Magnetic resonance imaging registration and quantification of the brain before and after coronary artery bypass surgery. Ann Thorac Surg. 2002; 73: S363-S365. (Pubitemid 34084619)
110. Restrepo L, Wityk RJ, Grega MA, et al. Diffusion-weighted magnetic resonance imaging of the brain before and after coronary bypass grafting surgery. Stroke. 2002; 33: 2909-2915. (Pubitemid 35462865)
111. Daabees TT, Finkelstein MW, Stegink LD, et al. Correlation of glutamate plus aspartate doses, plasma amino acid concentration and neuronal necrosis in infant mice. Food Chem Toxicol. 1985; 23: 887-893.
112. Svedjeholm R, Huljebrant I, Hakanson E, et al. Glutamate and high-dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations. Ann Thorac Surg. 1995; 59: S23-S30.
113. Knipp SC, Matatko N, Schlamann M, et al. Small ischemic brain lesions after cardiac valve replacement detected by diffusion-weighted magnetic resonance imaging: relation to neurocognitive function. Eur J Cardiothorac Surg. 2005; 28: 88-96. (Pubitemid 40883939)
114. Miyano H, Inagaki M, Hashimoto N, et al. Regional cerebral blood flow during rewarming of cardiopulmonary bypass correlates with posthypothermic regional glucose use. J Thorac Cardiovasc Surg. 1998; 116: 503-510. (Pubitemid 28400181)
115. Barber PA, Hach S, Tippett LJ, et al. Cerebral ischemic lesions on diffusionweighted imaging are associated with neurocognitive decline after cardiac surgery. Stroke. 2008; 39: 1427-1433.
116. Selnes OA, Royall RM, Grega MA, et al. Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline? Arch Neurol. 2001; 58: 598-604.
117. Stygall J, Newman SP, Fitzgerald G, et al. Cognitive change 5 years after coronary artery bypass surgery. Health Psychol. 2003; 22: 579-586. (Pubitemid 37466945)
118. van Dijk D, Spoor M, Hijman R, et al. Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery. JAMA. 2007; 297: 701-708. (Pubitemid 46294559)
119. Jensen BO, Rasmussen LS, Steinbruchel DA. Cognitive outcomes in elderly high-risk patients 1 year after off-pump versus on-pump coronary artery bypass grafting. A randomized trial. Eur J Cardiothorac Surg. 2008; 34: 1016-1021.
120. Jensen BO, Hughes P, Rasmussen LS, et al. Cognitive outcomes in elderly high-risk patients after off-pump versus conventional coronary artery bypass grafting: a randomized trial. Circulation. 2006; 113: 2790-2795. (Pubitemid 44305290)
121. Sweet JJ, Finnin E, Wolfe PL, et al. Absence of cognitive decline one year after coronary bypass surgery: comparison to nonsurgical and healthy controls. Ann Thorac Surg. 2008; 85: 1571-1578. (Pubitemid 351621916)
122. Rasmussen LS. Postoperative cognitive dysfunction: incidence and prevention. Best Pract Res Clin Anaesthesiol. 2006; 20: 315-330.
123. McKhann GM, Grega MA, Borowicz LM, et al. Is there cognitive decline 1 year after CABG? Comparison with surgical and nonsurgical controls. Neurology. 2005; 65: 991-999.
124. Kadoi Y, Goto F. Factors associated with postoperative cognitive dysfunction in patients undergoing cardiac surgery. Surg Today. 2006; 36: 1053-1057. (Pubitemid 44819447)
125. Kadoi Y, Saito S, Fujita N, et al. Risk factors for cognitive dysfunction after coronary artery bypass graft surgery in patients with type 2 diabetes. J Thorac Cardiovasc Surg. 2005; 129: 576-583. (Pubitemid 40311317)
126. Raymond PD, Radel M, Ray MJ, et al. Investigation of factors relating to neuropsychological change following cardiac surgery. Perfusion. 2007; 22: 27-33. (Pubitemid 47018359)
127. Ho PM, Arciniegas DB, Grigsby J, et al. Predictors of cognitive decline following coronary artery bypass graft surgery. Ann Thorac Surg. 2004; 77: 597-603. (Pubitemid 38186517)
128. Musumeci F, Feccia M, MacCarthy PA, et al. Prospective randomized trial of single clamp technique versus intermittent ischaemic arrest: myocardial and neurological outcome. Eur J Cardiothorac Surg. 1998; 13: 702-709. (Pubitemid 28313801)
129. Murkin JM, Newman SP, Stump DA, et al. Statement of consensus on assessment of neurobehavioral outcomes after cardiac surgery. Ann Thorac Surg. 1995; 59: 1289-1295.
130. Newman MF, Wolman R, Kanchuger M, et al. Multicenter preoperative stroke risk index for patients undergoing coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Circulation. 1996; 94: 1174-1180.
131. Al-Ruzzeh S, George S, Bustami M, et al. Effect of off-pump coronary artery bypass surgery on clinical, angiographic, neurocognitive and quality of life outcomes: randomized controlled trial. BMJ. 2006; 332: 1365. (Pubitemid 44365352)
132. Boeken U, Litmathe J, Feindt P, et al. Neurological complications after cardiac surgery: risk factors and correlation to the surgical procedure. Thorac Cardiovasc Surg. 2005; 53: 33-36. (Pubitemid 40288940)
133. Boyagian RA, Otis SM, Tyner JJ, et al. Study design validation for consolidating global with focal neurological events in cardiac surgery stroke risk factor analyses. Eur J Neurol. 2003; 10: 71-74.
134. Carrascal Y, Guerrero AL, Maroto LC, et al. Neurological complications after 2528 cardiopulmonary bypass. Eur Neurol. 1999; 41: 128-134. (Pubitemid 29176559)
135. Dubinsky RM, Lai SM. Mortality from combined carotid endarterectomy and coronary artery bypass surgery in the US. Neurology. 2007; 16: 195-197. (Pubitemid 46105736)
136. Cywinski JB, Koch CG, Krajewski LP, et al. Increased risk associated with combined carotid endarterectomy and coronary artery bypass graft surgery: a propensity-matched comparison with isolated coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2006; 20: 796-802.
137. Akins CW, Hilgenberg AD, Vlahakes GJ, et al. Late results of combined carotid and coronary surgery using actual versus actuarial methodology. Ann Thorac Surg. 2005; 80: 2091-2097.
138. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high risk patients. N Engl J Med. 2004; 351: 1493-1501.
139. Hobson RW. CREST (Carotid Revascularization Endarterectomy versus Stent Trial) : background, design, and current status. Semin Vasc Surg. 2000; 13: 139-143.
140. McPhee JT, Hill JS, Ciocca RG, et al. Carotid endarterectomy was performed with lower stroke and death rates than carotid artery stenting in the United States in 2003 and 2004. J Vasc Surg. 2007; 46: 1112-1118.
141. Marine LA, Rubin BG, Reddy R, et al. Treatment of asymptomatic carotid artery disease: similar early outcomes after carotid stenting for high-risk patients and endarterectomy for standard-risk patients. Vasc Surg. 2006; 43: 953-958. (Pubitemid 44308185)
142. Timaran CH, Rosero EB, Smith ST, et al. Trends and outcomes of concurrent carotid revascularization and coronary bypass. J Vasc Surg. 2008; 48: 355-360.
143. Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006; 19: 355:1660-1671. (Pubitemid 44583956)
144. Rorick MB, Furlan AJ. Risk of cardiac surgery in patients with previous stroke. Neurology. 1990; 40: 835-837. (Pubitemid 20159626)
145. Mizuno T, Toyama M, Tabuchi N, et al. Thickened intima of the aortic arch is a risk factor for stroke with coronary artery bypass grafting. Ann Thorac Surg. 2000; 1565-1570.
146. Taylor KM. Central nervous system effects of cardiopulmonary bypass. Ann Thorac Surg. 1998; 66 (suppl 5) : S20-S24. (Pubitemid 29030301)
147. Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001; 344: 395-402. (Pubitemid 32128671)
148. Lelis RG, Krieger JE, Pereira AC, et al. Apolipoprotein E4 genotype increases the risk of postoperative cognitive dysfunction in patients undergoing coronary artery bypass graft surgery. J Cardiovasc Surg (Torino). 2006; 47: 451-456. (Pubitemid 44463386)
149. Silbert BS, Evered LA, Scott DA, et al. The apolipoprotein E epsilon4 allele is not associated with cognitive dysfunction in cardiac surgery. Ann Thorac Surg. 2008; 86: 841-847.
150. Askar FZ, Cetin HY, Kumral E, et al. Apolipoprotein E epsilon4 allele and neurobehavioral status after on-pump coronary artery bypass grafting. J Card Surg. 2005; 20: 501-505. (Pubitemid 41742914)
151. Hogue CW Jr, Sundt T III, Barzilai B, et al. Cardiac and neurologic complications identify risks for mortality for both men and women undergoing coronary artery bypass graft surgery. Anesthesiology. 2001; 95: 1074-1078. (Pubitemid 33043219)
152. Hogue CW Jr, Barzilai B, Pieper KS, et al. Sex differences in neurological outcomes and mortality after cardiac surgery: a society of thoracic surgery national database report. Circulation. 2001; 103: 2133-2137. (Pubitemid 32458321)
153. Creswell LL. Postoperative atrial arrhythmias: risk factors and associated adverse outcomes. Semin Thorac Cardiovasc Surg. 1999; 11: 303-307.
154. D'Agostino RS, Svensson LG, Neumann DJ, et al. Screening carotid ultrasonography and risk factors for stroke in coronary artery surgery patients. Ann Thorac Surg. 1996; 62: 1714-1723. (Pubitemid 26421105)
155. Mickleborough LL, Walker PM, Takagi Y, et al. Risk factors for stroke in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1996; 112: 1250-1258. (Pubitemid 26403421)
156. Ozatik MA, Göl MK, Fansa I, et al. Risk factors for stroke following coronary artery bypass operations. J Card Surg. 2005; 20: 52-57. (Pubitemid 40175298)
157. Wareing TH, Dávila-Román VG, Barzilai B. Management of severely atherosclerotic ascending aorta during cardiac operations. A strategy for detection and treatment. J Thorac Cardiovasc Surg. 1992; 103: 453-462.
158. Scarborough JE, White W, Derilus FE, et al. Combined use of off-pump techniques and a sutureless proximal aortic anastomotic device reduces cerebral microemboli generation during coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003; 126: 1561-1567. (Pubitemid 37449187)
159. Hammon JW, Stump DA, Butterworth JF, et al. Single cross-clamp improves 6-month cognitive outcome in high risk coronary bypass patients: the effect of reduced aortic manipulations. J Thorac Cardiovasc Surg. 2006; 131: 114-121.
160. Weinstein GS. Left hemispheric strokes in coronary surgery: implications for end-hole aortic cannulas. Ann Thorac Surg. 2001; 71: 128-132.
161. Reichenspurner H, Navia JA, Bery G, et al. Particulate emboli capture by intra-aortic filter device during cardiac surgery. J Thorac Cardiovasc Surg. 2000; 119: 233-241. (Pubitemid 30091796)
162. Eifert S, Reichenspurner H, Pfefferkorn T, et al. Neurological and neuropsychological examination and outcome after use of an intra-aortic filter device during cardiac surgery. Perfusion. 2003; 18 (suppl 1) : 55-60. (Pubitemid 36503930)
163. Grooters RK, Thieman KC, Schneider RF, et al. Assessment of perfusion toward the aortic valve. Tex Heart Inst J. 2000; 27: 361-365.
164. Johnson WD, Ganjoo AK, Stone CD. Left atrial appendage: our more lethal human attachment!Surgical implications. Eur J Cardiothorac Surg. 2000; 17: 18-22.
165. Svenarud P, Persson M, van der Linden J. Effect of CO2 insufflation on the number and behavior of air microemboli in open-heart surgery. A randomized clinical trial. Circulation. 2004; 109: 1127-1132.
166. Kalpokas MV, Nixon IK, Kluger R, et al. Carbon dioxide field flooding versus mechanical de-airing during open-heart surgery: a prospective randomized controlled trial. Perfusion. 2003; 18: 291-294. (Pubitemid 37369284)
167. Whitaker DC, Newman SP, Stygall J, et al. The effect of leucocyte-depleting arterial line filters on cerebral microemboli and neuropsychological outcome following coronary artery bypass surgery. Eur J Cardiothorac Surg. 2004; 25: 267-274. (Pubitemid 38125093)
168. Anderson RE, Hansson LO, Liska J, et al. The effect of cardiotomy suction on the brain injury marker S100ß after cardiopulmonary bypass. Ann Thorac Surg. 2000; 69: 847-850. (Pubitemid 30184707)
169. Jönsson H, Holm C, Nilsson A, et al. Particle separation using ultrasound can radically reduce embolic load to brain after cardiac surgery. Ann Thorac Surg. 2004; 78: 1572-1577. (Pubitemid 39423514)
170. Eyjolfsson A, Scicluna S, Johnsson P, et al. Characterization of lipid particles in shed mediastinal blood. Ann Thorac Surg. 2008; 85: 978-981. (Pubitemid 351255537)
171. Jönsson H, Nilsson A, Petersson F, et al. Particle separation using ultrasound can be used with human shed mediastinal blood. Perfusion. 2005; 20: 39-43. (Pubitemid 40298234)
172. Martin TC, Craver JM, Goot JP, et al. Prospective, randomized trial of retrograde warm-blood cardioplegia: myocardial benefit and neurologic treat. Ann Thorac Surg. 1994; 57: 298-304.
173. McLean RF, Wong BI, Naylor CD, et al. Cardiopulmonary bypass, temperature, and central nervous system dysfunction. Circulation. 1994; 90: II250 - II255.
174. Mora CT, Henson MB, Weintraub WS, et al. The effect of temperature management during cardiopulmonary bypass on neurologic and neuropsychologic outcomes inpatients undergoing coronary revascularization. J Thorac Cardiovasc Surg. 1996; 112: 514-522.
175. Duebener LF, Hagino I, Sakamoto T, et al. Effects of pH management during deep hypothermic bypass on cerebral microcirculation: alpha-stat versus pH-stat. Circulation. 2002; 106 (suppl 1) : I103-I108.
176. Sauren LD, la Meir M, Palmen M, et al. New ultrasonic radiation reduces cerebral emboli during extracorporeal circulation. Eur J Cardiothorac Surg. 2007; 32: 274-280. (Pubitemid 47021419)
177. Pepin E, Dulan S. Effects of mean arterial pressure on cerebral perfusion during cardiopulmonary bypass: a review. J Extra Corpor Technol. 2003; 35: 297-303. (Pubitemid 38140662)
178. Mangano DT, Tudor IC, Dietzel C, et al.; Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006; 26: 353-365.
179. Habib RH, Zacharias A, Schwann TA, et al. Adverse effects of low hematocrit during cardiopulmonary bypass in the adult: should current practice be changed? J Thorac Cardiovasc Surg. 2003; 125: 1438-1450. (Pubitemid 36759247)
180. Mathew JP, Mackensen GB, Phillips-Bute B, et al. Effects of extreme hemodilution during cardiac surgery on cognitive function in the elderly. Anesthesiology. 2007; 107: 577-584. (Pubitemid 47480563)
181. Butterworth J, Wagenknecht LE, Legault C, et al. Attempted control of hyperglycemia during cardiopulmonary bypass fails to improve neurologic or neurobehavioral outcomes in patients without diabetes mellitus undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2005; 130: 1319. (Pubitemid 41543200)
182. Kinkaid EH, Jones TJ, Stump DA, et al. Processing scavenged blood with a cell saver reduces cerebral lipid microembolization. Ann Thorac Surg. 2000; 70: 1296-1300.
183. Schmitt KR, Kern C, Berger F, et al. Methylprednisolone attenuates hypothermia-and rewarming-induced cytotoxicity and IL-6 release in isolated primary astrocytes, neurons and BV-2 microglia cells. Neurosci Lett. 2006; 404: 309-314. (Pubitemid 44131623)
184. Roach GW, Newman MF, Murkin JM, et al. Ineffectiveness of burst suppression therapy in mitigating perioperative cerebrovascular dysfunction. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Anesthesiology. 1991; 90: 1255-1264.
185. Mills SA, Prougth DS. Neuropsychiatric complications following cardiac surgery. Sem Thorac Cardiovasc Surg. 1991; 3: 39-46.
186. Grocott HP, Nussmeier NA. Neuroprotection in cardiac surgery. Anesthesiol Clin North Am. 2003; 21: 487-509.
187. Menasché P, Pasquier C, Bellucci S, et al. Deferoxamine reduces neutrophilmediated free radical production during cardiopulmonary bypass in man. J Thorac Cardiovasc Surg. 1988; 96: 582-589.
188. Hirotani T, Kameda T, Kumamoto T, et al. Aortic arch repair using hypothermic circulatory arrest technique associated with pharmacological brain protection. Eur J Cardiothorac Surg. 2000; 18: 545-549.
189. Yoshimura N, Okada M, Ota T, et al. Pharmacologic intervention for ischemic brain edema after retrograde cerebral perfusion. J Thorac Cardiovasc Surg. 1995; 109: 1173-1181.
190. Coetzee A, Roussouw G, Macgregor L. Failure of allopurinol to improve left ventricular stroke work after cardiopulmonary bypass surgery. J Cardiothorac Vasc Anesth. 1996; 10: 627-633. (Pubitemid 26264686)
191. Shake JG, Peck EA, Marban E, et al. Pharmacologically induced preconditioning with diazoxide: a novel approach to brain protection. Ann Thorac Surg. 2001; 72: 1849-1854. (Pubitemid 34001428)
192. Caparrelli DJ, Cattaneo SM II, Bethea BT, et al. Pharmacological preconditioning ameliorates neurological injury in a model of spinal cord ischemia seem to have a neuroprotective effect. Ann Thorac Surg. 2002; 74: 838-844.
193. Amory DW, Grigore A, Amory JK, et al. Neuroprotection is associated with beta-adrenergic receptor antagonist during cardiac surgery: evidence from 2, 575 patients. J Cardiothorac Vasc Anesth. 2002; 16: 270-277. (Pubitemid 34701175)
194. Butterworth J, Hammon JW. Lidocaine for neuroprotection: more evidence of efficacy. Anesth Analg. 2002; 95: 1131-1133. (Pubitemid 35239092)
195. Legault C, Furberg CD, Wagenknecht LE, et al. Nimodipine neuroprotection in cardiac valve replacement: report of an early terminated trial. Stroke. 1996; 27: 593-598. (Pubitemid 26114415)
196. Taggart D, Brownw SM, Wade DT, et al. Neuroprotection during cardiac surgery: a randomized trial of a platelet activating factor antagonist. Heart. 2003; 89: 897-900. (Pubitemid 36920816)
197. Aoki M, Jonas RA, Nomura F, et al. Effects of aprotinin on acute recovery of cerebral metabolism in piglets after hypothermic circulatory arrest. Ann Thorac Surg. 1994; 58: 146-153. (Pubitemid 24243920)
198. Iwata Y, Nicole O, Okamura T, et al. Aprotinin confers neuroprotection by reducing excitotoxic cell death. J Thorac Cardiovasc Surg. 2008; 135: 573-578.
199. Arrowsmith JE, Harrison MJ, Newman SP, et al. Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients. Stroke. 1998; 29: 2357-2362.
200. Olney JW, Labruyere J, Wang G, et al. NMDA antagonist neurotoxicity: mechanism and prevention. Science. 1991; 254: 1515-1518. (Pubitemid 21917493)
201. Meldrum B, Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci. 1990; 11: 379-387. (Pubitemid 20262465)
202. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994; 330: 613-622.
203. Redmond JM, Zehr KJ, Blue ME, et al. AMPA glutamate receptor antagonism reduces neurologic injury after hypothermic circulatory arrest. Ann Thorac Surg. 1995; 59: 579-584.
204. Baumgartner WA, Walinsky PL, Salazar JD, et al. Assessing the impact of cerebral injury after cardiac surgery: will determining the mechanism reduce this injury? Ann Thorac Surg. 1999; 67: 1871-1873.
205. Tseng EE, Brock MV, Kwon CC, et al. Increased intracerebral excitatory amino acids and nitric oxide after hypothermic circulatory arrest. Ann Thorac Surg. 1999; 67: 371-376.
206. Kanazawa Y, Makino M, Morishima Y, et al. Degradation of PEP-19, a calmodulin-binding protein, by calpain is implicated in neuronal cell death induced by intracellular Ca2+ overload. Neuroscience. 2008; 154: 473-481.
207. Zhang Y, Bhavnani BR. Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens. BMCNeurosci. 2006; 7: 49. (Pubitemid 44203258)
208. Hiramatsu Y, Homma S, Sato Y, et al. Nafamostat preserves neutrophil deformability and reduces microaggregate formation during simulated extracorporeal circulation. Ann Thorac Surg. 2005; 79: 1326-1332. (Pubitemid 40431860)
209. Kaminishi Y, Hitamatsu Y, Watanabe Y, et al. Effects of nafamostat mesilate and minimal-dose aprotinin on blood foreign surface interactions in cardiopulmonary bypass. Ann Thorac Surg. 2004; 77: 644-650. (Pubitemid 38186526)
210. Elewa HF, Hilali H, Hess DC, et al. Minociclyne for short-term neuroprotection. Pharmacotherapy. 2006; 26: 515-521.
211. Pi R, Li W, Lee NT, et al. Minocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways. J Neurochem. 2004; 91: 1219-1230. (Pubitemid 39587460)
212. Komeda M. Treatment of atrial fibrillation: is it really going to be a surgical market? Ann Thorac Cardiovasc Surg. 2008; 14: 63-65.
213. Misaki T, Fukahara K. Recent topics on the surgical treatment for atrial fibrillation. Ann Thorac Cardiovasc Surg. 2004; 10: 277-280.